Cooperative Agreement for the Provider’s Clinical Support System – Medication Assisted Treatment Supplement

Short Title: 
PCSS-MAT Supplement
Initial Announcement
Funding Opportunity Announcement (FOA) Information
FOA Number: 
TI-17-003
Posted on Grants.gov: 
Tuesday, December 27, 2016
Application Due Date: 
Friday, March 3, 2017
Catalog of Federal Domestic Assistance (CFDA) Number: 
93.243
Intergovernmental Review (E.O. 12372): 
Applicants must comply with E.O. 12372 if their state(s) participates. Review process recommendations from the State Single Point of Contact (SPOC) are due no later than 60 days after application deadline.
Public Health System Impact Statement (PHSIS) / Single State Agency Coordination: 
Applicants must send the PHSIS to appropriate State and local health agencies by application deadline. Comments from Single State Agency are due no later than 60 days after application deadline.
Description

The Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Substance Abuse Treatment (CSAT) announces the availability of two-year supplemental funding to enable the grantee from the Fiscal Year (FY) 2016 Cooperative Agreement for the Provider’s Clinical Support System - Medication Assisted Treatment (PCCS-MAT) cohort to expand/enhance grant activities required under the FY 2016 Funding Opportunity Announcement (FOA). Information on this program may be found in the original funding announcement, TI-16-003 available on the SAMHSA website at http://www.samhsa.gov/grants/grant-announcements/ti-16-003.

The Cooperative Agreement for the Provider’s Clinical Support System – Medication Assisted Treatment Supplement (Short Title: PCSS-MAT Supplement) program purpose is to expand on the Drug Addiction Treatment Act (DATA) of 2000 and continue SAMHSA’s currently funded PCSS-MAT initiative. The current PCSS-MAT initiative has provided 267 wavier trainings, 88 online continuing medical educational/clinical educational (CME/CE) courses, a no cost clinical coaching/mentoring support for all health professionals in primary care, and has trained over 32,000 health professionals. The PCSS-MAT program has provided up-to-date and evidence-based information to support the training of health professionals and to address the complex issues of substance use disorders, addiction, and co-occurring mental disorders. This supplement will provide additional support to the current PCSS-MAT grantee by enhancing/expanding medication assisted treatment (MAT) training and educational resources to health professionals on evidence-based practices for preventing, identifying, and treating opioid use disorders. Grant funds received under this supplement may only be used to support new activities and to serve new populations. PCSS-MAT Supplement funds need to be tracked separately from original grant (TI-16-003) funds.

Eligibility

Eligibility is limited to the current SAMHSA FY 2016 PCCS-MAT grantee, the American Academy of Addiction Psychiatry. Eligibility is limited because this is the most effective way to accomplish the goals of this two-year supplement since the current grantee has the necessary knowledge, experience, and key partnerships in place to carry out grant activities without a lengthy start-up period.

Award Information
Funding Mechanism: 
Cooperative Agreement
Anticipated Total Available Funding: 
$1 million
Anticipated Number of Awards: 
One (1) award
Anticipated Award Amount: 
Up to $1 million
Length of Project: 
Up to two (2) years
Cost Sharing/Match Required?: 
No

Proposed budgets cannot exceed the allowable amount in any year of the supplement. Annual continuation awards will depend on the availability of funds, grantee progress in meeting project goals and objectives, timely submission of required data and reports, and compliance with all terms and conditions of award.

Funding estimates for this announcement are based on an annualized Continuing Resolution and do not reflect the final FY 2017 appropriation. Applicants should be aware that funding amounts are subject to the availability of funds.

Contact Information
Program Issues

Anthony Campbell RPH, D.O., Medical Officer
Center for Substance Abuse Treatment, Division of Pharmacologic Therapies
Substance Abuse and Mental Health Services Administration
(240) 276-2702
Tony.campbell@samhsa.hhs.gov

Grants Management and Budget Issues

Eileen Bermudez
Office of Financial Resources, Division of Grants Management
Substance Abuse and Mental Health Services Administration
(240) 276-1412
FOACSAT@samhsa.hhs.gov

Application Materials

You must respond to the requirements in both the FOA PART I and PART II when preparing your application.

Useful Information for Applicants

Last Updated: 12/27/2016